| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/27/2002 | CA2782615A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/27/2002 | CA2782521A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 12/27/2002 | CA2782519A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 12/27/2002 | CA2782517A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 12/27/2002 | CA2782515A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/27/2002 | CA2782494A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/27/2002 | CA2451874A1 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 12/27/2002 | CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450856A1 Novel aliphatic compounds, their synthesis method, and utilization method of the same |
| 12/27/2002 | CA2450809A1 Methods for detecting and treating the early onset of aging-related conditions |
| 12/27/2002 | CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450659A1 Tryptase inhibitors |
| 12/27/2002 | CA2450074A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage |
| 12/27/2002 | CA2450067A1 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | CA2449977A1 Human growth hormone antagonists |
| 12/27/2002 | CA2449916A1 Imidazole derivatives for modulating sodium channels |
| 12/27/2002 | CA2449898A1 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/27/2002 | CA2448298A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | CA2446285A1 Fibroblast growth factor and nucleic acid encoding same |
| 12/27/2002 | CA2443466A1 An aqueous pharmaceutical preparation of cilostazol for parenteral use |
| 12/27/2002 | CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/26/2002 | US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 12/26/2002 | US20020198259 Treatment of disease caused by procedural vascular trauma and/or an increased level of plasma homocysteine |
| 12/26/2002 | US20020198253 Melatonin derivatives and medicine containing same |
| 12/26/2002 | US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/26/2002 | US20020198248 Therapeutic methods and compositions involving isoflavones |
| 12/26/2002 | US20020198234 Identifying a patient suffering from fatigue arising from oncological condition, and administering to the patient a therapeutically effective amount of D-threo-methylphenidate free of 1-threo isomer |
| 12/26/2002 | US20020198232 4-substituted quinoline derivatives |
| 12/26/2002 | US20020198219 2-pyridinamine compositions and related methods |
| 12/26/2002 | US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions |
| 12/26/2002 | US20020198211 cDNA for human methylenetetrahydrofolate reductase and uses thereof |
| 12/26/2002 | US20020198199 Such as 2-(2-(N-((4-aminoiminomethylphenyl)methyl)-3-(3-aminophenyl)-6-(N,N -dimethylhydrazino)-1-oxypyridinyl))acetami de which inhibit serine proteases for preventing and treating thrombotis |
| 12/26/2002 | US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa |
| 12/26/2002 | US20020198193 Novel 5-thio-B-D-xylopryanoside derivatives, preparation, method, pharmaceutical compositions containing them and their therapeutic use |
| 12/26/2002 | US20020198191 Cyclohexylphenyl vasopressin agonists |
| 12/26/2002 | US20020198187 Method of treating sexual disturbances |
| 12/26/2002 | US20020198179 An estrogen or prodrug micture for reducing or eliminating the incidence of hot flashes and menopausal symptoms, while decreasing the risk of acquiring breast or endometrial cancer, inhibiting the development of osteoporosis |
| 12/26/2002 | US20020198177 Coenzyme Q and EPA |
| 12/26/2002 | US20020198152 Administering to an obese patient or one at risk of becoming obese a therapeutic compound that attenuates the binding of agouti-related protein to melanocortin receptors, free of binding of alpha-melanocyte stimulating hormone to receptor |
| 12/26/2002 | US20020198143 B7-like polynucleotides, polypeptides, and antibodies |
| 12/26/2002 | US20020198142 Integrin inhibitors, for the treatment of disorders caused by implants, defects, inflammations and of osteolytic disorders such as osteoporosis, thrombosis, cardiac infarct and arteriosclerosis |
| 12/26/2002 | US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 12/26/2002 | US20020197331 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 12/26/2002 | US20020197325 Microparticles |
| 12/26/2002 | US20020197246 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 12/26/2002 | US20020197233 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 12/25/2002 | CN1387577A Process for producing product contg. antihypertensive tripeptides |
| 12/25/2002 | CN1387564A Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 12/25/2002 | CN1387531A Pyrazolo [4,3-d] pyrimidine derivs. |
| 12/25/2002 | CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors |
| 12/25/2002 | CN1387528A Heterocyclic substd, pyrazolones |
| 12/25/2002 | CN1387527A Qinazoline derivs. as VEGF inhibitors |
| 12/25/2002 | CN1387526A Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof |
| 12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 12/25/2002 | CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 12/25/2002 | CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 12/25/2002 | CN1387450A Use of dopamine-D3 receptor agonists for therapy of salt-dependent hypertension |
| 12/25/2002 | CN1387440A Methods for treating diabetes |
| 12/25/2002 | CN1387430A Liver selective therapy |
| 12/25/2002 | CN1386744A Process for extracting triterpenic acid from gleditschia, and medical use and Chinese medicine of triterpenic acid |
| 12/25/2002 | CN1386742A Flavone derivatives and preparing process and use thereof |
| 12/25/2002 | CN1386544A Medicinally health-care powder made of ganoderma and lentinan |
| 12/25/2002 | CN1386541A Zhenzhu pill and its preparing process |
| 12/25/2002 | CN1386538A Weight-lossing antihypertensive liquid and its preparing process |
| 12/25/2002 | CN1386537A Oral liquid of hare's-lettuce |
| 12/25/2002 | CN1386526A Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 12/25/2002 | CN1386502A Application of niflumic acid in preventing and treating arrhythmia |
| 12/25/2002 | CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof |
| 12/25/2002 | CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists |
| 12/25/2002 | CN1097050C Substd 2,4-imidazolidinedione compounds and pharmaceutical active ingredients |
| 12/25/2002 | CN1096853C Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498274 Amide derivatives for the treatment of diseases mediated by cytokines |
| 12/24/2002 | US6498243 Epimorphin antagonist and process for producing it |
| 12/24/2002 | US6498233 Nucleic acid transfer system |
| 12/24/2002 | US6498191 For treatment of alzheimer's disease, diabetes mellitus, parkinson's disease, neuronal and cardiac ischemia, huntington's disease, stroke |
| 12/24/2002 | US6498178 Inhibitors of IMPDH enzyme |
| 12/24/2002 | US6498177 Alpha 2 adrenergic receptor agonist; analgesic, sedative and anaesthetic agents |
| 12/24/2002 | US6498174 Agonists to peroxisome proliferator-activated receptors; modulating blood glucose and lipid levels; reducing dyslipidemia and hyperinsulinemia associated with impaired glucose tolerance or metabolic syndrome |
| 12/24/2002 | US6498173 Treatment of diseases based on acute or chronic obstruction of vessels and/or bronchi and/or inflammation |
| 12/24/2002 | US6498161 Treating infection by hiv; delaying of the onset of aids; asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis |
| 12/24/2002 | US6498156 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 12/24/2002 | US6498152 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis |
| 12/24/2002 | US6498151 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors |
| 12/24/2002 | US6498142 Osteogenic protein-1 (op-1) and other members of the op-1 subfamily of the tgf-.beta. superfamily of growth factors |
| 12/24/2002 | US6497699 Hybrid neuroprosthesis for the treatment of brain disorders |
| 12/24/2002 | CA2075878C Cyclic peptides and use thereof |
| 12/24/2002 | CA2054339C 3-amidoindolyl derivatives |
| 12/21/2002 | CA2390966A1 Compound for the treatment of atherosclerotic-thrombotic pathological conditions |
| 12/19/2002 | WO2002101392A2 Methods for treating disorders of the nervous and reproductive systems |
| 12/19/2002 | WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE |
| 12/19/2002 | WO2002101005A2 A g-protein coupled receptor and uses therefor |
| 12/19/2002 | WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein |
| 12/19/2002 | WO2002100888A1 Somatostatin-dopamine chimeric analogs |
| 12/19/2002 | WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 12/19/2002 | WO2002100865A1 Benzoxazepine derivatives and their use as ampa receptor stimulators |
| 12/19/2002 | WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 12/19/2002 | WO2002100859A1 Pde iv inhibitors |
| 12/19/2002 | WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |